252 related articles for article (PubMed ID: 33144412)
1. Telomere Length and Hematological Disorders: A Review.
Nogueira BMD; Machado CB; Montenegro RC; DE Moraes MEA; Moreira-Nunes CA
In Vivo; 2020; 34(6):3093-3101. PubMed ID: 33144412
[TBL] [Abstract][Full Text] [Related]
2. Telomerase and telomere biology in hematological diseases: A new therapeutic target.
Allegra A; Innao V; Penna G; Gerace D; Allegra AG; Musolino C
Leuk Res; 2017 May; 56():60-74. PubMed ID: 28196338
[TBL] [Abstract][Full Text] [Related]
3. The importance of the telomere and telomerase system in hematological malignancies.
Ram R; Uziel O; Lahav M
Leuk Lymphoma; 2005 Aug; 46(8):1121-35. PubMed ID: 16085552
[TBL] [Abstract][Full Text] [Related]
4. The role of telomeres and telomerase in hematologic malignancies and hematopoietic stem cell transplantation.
Wang L; Xiao H; Zhang X; Wang C; Huang H
J Hematol Oncol; 2014 Aug; 7():61. PubMed ID: 25139287
[TBL] [Abstract][Full Text] [Related]
5. Telomere dynamics in adult hematological malignancies.
Olbertova H; Plevova K; Stranska K; Pospisilova S
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2019 Feb; 163(1):1-7. PubMed ID: 30631211
[TBL] [Abstract][Full Text] [Related]
6. Telomere protein complexes and their role in lymphoid malignancies.
Panero J; Santos PD; Slavutsky I
Front Biosci (Schol Ed); 2017 Jan; 9(1):17-30. PubMed ID: 27814571
[TBL] [Abstract][Full Text] [Related]
7. The role of telomeres and telomerase complex in haematological neoplasia: the length of telomeres as a marker of carcinogenesis and prognosis of disease.
Gancarcíková M; Zemanová Z; Brezinová J; Berková A; Vcelíková S; Smigová J; Michalová K
Prague Med Rep; 2010; 111(2):91-105. PubMed ID: 20653999
[TBL] [Abstract][Full Text] [Related]
8. [Maintaining telomere length].
Wysoczańska B
Postepy Hig Med Dosw (Online); 2013 Dec; 67():1319-30. PubMed ID: 24379272
[TBL] [Abstract][Full Text] [Related]
9. Short telomeres resulting from heritable mutations in the telomerase reverse transcriptase gene predispose for a variety of malignancies.
Hills M; Lansdorp PM
Ann N Y Acad Sci; 2009 Sep; 1176():178-90. PubMed ID: 19796246
[TBL] [Abstract][Full Text] [Related]
10. Telomerase-based therapies in haematological malignancies.
Rafat A; Dizaji Asl K; Mazloumi Z; Movassaghpour AA; Farahzadi R; Nejati B; Nozad Charoudeh H
Cell Biochem Funct; 2022 Mar; 40(2):199-212. PubMed ID: 35103334
[TBL] [Abstract][Full Text] [Related]
11. Telomeres and telomerase in hematologic neoplasia.
Ohyashiki JH; Sashida G; Tauchi T; Ohyashiki K
Oncogene; 2002 Jan; 21(4):680-7. PubMed ID: 11850796
[TBL] [Abstract][Full Text] [Related]
12. Telomeres, telomerase, and hematopoietic stem cell biology.
Greenwood MJ; Lansdorp PM
Arch Med Res; 2003; 34(6):489-95. PubMed ID: 14734088
[TBL] [Abstract][Full Text] [Related]
13. Use of U-STELA for Accurate Measurement of Extremely Short Telomeres.
Serakinci N; Cagsin H; Mavis M
Methods Mol Biol; 2019; 2045():217-224. PubMed ID: 29542055
[TBL] [Abstract][Full Text] [Related]
14. Telomere and telomerase in stem cells.
Hiyama E; Hiyama K
Br J Cancer; 2007 Apr; 96(7):1020-4. PubMed ID: 17353922
[TBL] [Abstract][Full Text] [Related]
15. Telomere dysfunction and hematologic disorders.
Paiva RM; Calado RT
Prog Mol Biol Transl Sci; 2014; 125():133-57. PubMed ID: 24993701
[TBL] [Abstract][Full Text] [Related]
16. Telomeres and Telomerase in Hematopoietic Dysfunction: Prognostic Implications and Pharmacological Interventions.
Vasko T; Kaifie A; Stope MB; Kraus T; Ziegler P
Int J Mol Sci; 2017 Oct; 18(11):. PubMed ID: 29143804
[TBL] [Abstract][Full Text] [Related]
17. Telomeres and chromosomal instability.
Mathieu N; Pirzio L; Freulet-Marrière MA; Desmaze C; Sabatier L
Cell Mol Life Sci; 2004 Mar; 61(6):641-56. PubMed ID: 15052408
[TBL] [Abstract][Full Text] [Related]
18. Telomeres and telomerase in leukaemia and lymphoma.
Davison GM
Transfus Apher Sci; 2007 Aug; 37(1):43-7. PubMed ID: 17766184
[TBL] [Abstract][Full Text] [Related]
19. Alternative Lengthening of Telomeres (ALT) in Tumors and Pluripotent Stem Cells.
Zhao S; Wang F; Liu L
Genes (Basel); 2019 Dec; 10(12):. PubMed ID: 31835618
[TBL] [Abstract][Full Text] [Related]
20. New ways not to make ends meet: telomerase, DNA damage proteins and heterochromatin.
Chan SW; Blackburn EH
Oncogene; 2002 Jan; 21(4):553-63. PubMed ID: 11850780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
